HAPPINESS BIOTECH GROUP LTD (HAPP): Price and Financial Metrics


Today's Latest Price: $1.91 USD

0.04 (-2.05%)

Updated Dec 1 4:00pm

Add HAPP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

HAPP Stock Summary

  • With a one year PEG ratio of 0.51, Happiness Biotech Group Ltd is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 6.17% of US stocks.
  • HAPP's went public 1.1 years ago, making it older than only 0.72% of listed US stocks we're tracking.
  • HAPP's current price/earnings ratio is 3.84, which is higher than merely 2.75% of US stocks with positive earnings.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Happiness Biotech Group Ltd are UG, BHAT, GIGM, JOUT, and SCON.
  • HAPP's SEC filings can be seen here. And to visit Happiness Biotech Group Ltd's official web site, go to www.happ.org.cn.

HAPP Stock Price Chart Interactive Chart >

Price chart for HAPP

HAPP Price/Volume Stats

Current price $1.91 52-week high $6.10
Prev. close $1.95 52-week low $1.63
Day low $1.90 Volume 172,100
Day high $1.96 Avg. volume 375,221
50-day MA $1.81 Dividend yield N/A
200-day MA $2.62 Market Cap 49.47M


Happiness Biotech Group Ltd. is a nutraceutical and dietary supplements producer, which engages in the research, development, manufacturing, marketing, and sales of a variety of products made from herbal and animal extracts. The firm's products include lucidum spore powder; cordyceps mycelia; ijiao solution; and American ginseng. It operates under the brand name Happiness. The company was founded on February 9, 2018 and is headquartered in Nanping City, China.

HAPP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$1.91$0.84 -57%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Happiness Biotech Group Ltd. To summarize, we found that Happiness Biotech Group Ltd ranked in the 30th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Happiness Biotech Group Ltd, consider:

  • The compound growth rate in the free cash flow of Happiness Biotech Group Ltd over the past 1.08 years is -0.23%; that's higher than just 7.51% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet reveals debt to be 4% of the company's capital (with equity being the remaining amount). Approximately only 14.09% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

PCRX, HSIC, CDNA, IONS, and JNJ can be thought of as valuation peers to HAPP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

HAPP Latest News Stream

Event/Time News Detail
Loading, please wait...

HAPP Latest Social Stream

Loading social stream, please wait...

View Full HAPP Social Stream

Latest HAPP News From Around the Web

Below are the latest news stories about Happiness Biotech Group Ltd that investors may wish to consider to help them evaluate HAPP as an investment opportunity.

Happiness Biotech launches $2.25M private support

Happiness Biotech ([[HAPP]] +15.5%) entered into a certain securities purchase agreement with three non-U.S. investors under which it has agreed to sell 900K ordinary shares at $2.5/share.Gross proceeds to be used for the development of Happy Buy's B2B e-Commerce business as well as for working capital and general corporate use."In addition to the capital,...

Seeking Alpha | September 25, 2020

Happiness Biotech Group Limited declares special dividend of $0.015

Happiness Biotech Group Limited (HAPP) declares $0.015/share special dividend.Payable Aug. 17; for shareholders of record Aug. 10; ex-div Aug. 7....

Seeking Alpha | July 31, 2020

Happiness Biotech Declares Special Cash Dividends to Shareholders

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has declared a cash dividend of $0.015 per ordinary share, payable in cash on or about August 17, 2020, to shareholders of record on August 10, 2020.

Yahoo | July 31, 2020

Happiness Biotech Announces Financial Results for Fiscal Year Ended March 31, 2020

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its financial results for the fiscal year ended March 31, 2020.

Yahoo | July 24, 2020

Happiness Biotech Announced Receipt of NPN License in Canada for Its Hand Sanitizer

Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the 75% Alcohol Disposable Hand Sanitizer from the Company has successfully obtained Natural Product Number (NPN) license from Health Canada and the first order of 53,280 bottles have been shipped this week.

Yahoo | July 7, 2020

Read More 'HAPP' Stories Here

HAPP Price Returns

1-mo 13.02%
3-mo -2.55%
6-mo -29.52%
1-year -59.74%
3-year N/A
5-year N/A
YTD -58.07%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6833 seconds.